Page last updated: 2024-10-24

leukocyte differentiation

Definition

Target type: biologicalprocess

The process in which a relatively unspecialized hemopoietic precursor cell acquires the specialized features of a leukocyte. A leukocyte is an achromatic cell of the myeloid or lymphoid lineages capable of ameboid movement, found in blood or other tissue. [CL:0000738, GOC:add, PMID:16551264]

Leukocyte differentiation is a complex process that involves a series of tightly regulated steps, leading to the generation of diverse, specialized immune cells from hematopoietic stem cells (HSCs). This process is crucial for maintaining immune system homeostasis and responding effectively to various challenges, such as infections, tissue damage, and cancer.

**1. Hematopoietic Stem Cells (HSCs)**

HSCs reside in the bone marrow and possess the remarkable ability to self-renew and differentiate into all blood cell lineages, including leukocytes. HSCs are characterized by their expression of specific cell surface markers and their ability to give rise to all other hematopoietic cells.

**2. Commitment and Differentiation**

HSCs undergo a series of commitment steps, progressively restricting their differentiation potential toward specific leukocyte lineages. This commitment process is influenced by a complex interplay of intrinsic factors, such as transcription factors, and extrinsic signals, including cytokines and growth factors.

**3. Common Myeloid Progenitor (CMP)**

HSCs first differentiate into a CMP, which has the potential to give rise to granulocytes, monocytes, macrophages, and dendritic cells.

**4. Granulocyte-Monocyte Progenitor (GMP)**

The CMP further differentiates into a GMP, which commits to either the granulocyte or monocyte lineage.

**5. Granulocyte Lineage:**

* **Neutrophils:** The most abundant leukocytes, neutrophils are phagocytic cells that play a critical role in combating bacterial infections.
* **Eosinophils:** Eosinophils are involved in allergic reactions and parasitic infections.
* **Basophils:** Basophils release histamine and other inflammatory mediators during allergic reactions.

**6. Monocyte Lineage:**

* **Monocytes:** Monocytes circulate in the bloodstream and can differentiate into macrophages and dendritic cells in tissues.
* **Macrophages:** Macrophages are phagocytic cells that engulf and destroy pathogens, cellular debris, and foreign particles.
* **Dendritic Cells:** Dendritic cells act as antigen-presenting cells, capturing and presenting antigens to T lymphocytes, initiating adaptive immune responses.

**7. Common Lymphoid Progenitor (CLP)**

HSCs can also differentiate into a CLP, which commits to the lymphoid lineage, giving rise to T lymphocytes, B lymphocytes, and natural killer (NK) cells.

**8. T Lymphocyte Development:**

T lymphocytes develop in the thymus and undergo a process of selection to ensure self-tolerance and antigen specificity.

**9. B Lymphocyte Development:**

B lymphocytes develop in the bone marrow and differentiate into antibody-producing plasma cells.

**10. Natural Killer (NK) Cell Development:**

NK cells develop in the bone marrow and contribute to innate immunity by killing virus-infected cells and tumor cells.

**11. Regulation of Leukocyte Differentiation:**

The differentiation of leukocytes is tightly regulated by a complex interplay of:

* **Transcription Factors:** Specific transcription factors are expressed in different stages of leukocyte development and control the expression of genes involved in lineage commitment and differentiation.
* **Cytokines and Growth Factors:** Cytokines and growth factors, such as granulocyte colony-stimulating factor (G-CSF) and macrophage colony-stimulating factor (M-CSF), provide crucial signals for cell survival, proliferation, and differentiation.
* **Microenvironment:** The bone marrow microenvironment, including stromal cells and extracellular matrix, plays a critical role in supporting HSCs and regulating leukocyte differentiation.

**12. Dysregulation of Leukocyte Differentiation:**

Dysregulation of leukocyte differentiation can lead to various immune disorders, including leukemia, lymphoma, and immunodeficiency.

**13. Therapeutic Applications:**

Understanding leukocyte differentiation has led to the development of new therapeutic strategies for treating immune disorders, such as stem cell transplantation and cytokine-based therapies.'
"

Proteins (1)

ProteinDefinitionTaxonomy
Methylcytosine dioxygenase TET2A methylcytosine dioxygenase TET2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q6N021]Homo sapiens (human)

Compounds (4)

CompoundDefinitionClassesRoles
alpha-hydroxyglutarate2-hydroxyglutarate : A dicarboxylic acid anion obtained by deprotonation of at least one of the carboxy groups of 2-hydroxyglutaric acid.

2-hydroxyglutaric acid : A 2-hydroxydicarboxylic acid that is glutaric acid in which one hydrogen alpha- to a carboxylic acid group is substituted by a hydroxy group.
2-hydroxydicarboxylic acid;
dicarboxylic fatty acid
metabolite;
mouse metabolite
deferoxamineDeferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.

desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
acyclic desferrioxaminebacterial metabolite;
ferroptosis inhibitor;
iron chelator;
siderophore
5-carboxy-8-hydroxyquinoline5-carboxy-8-hydroxyquinoline: a JmjC histone demethylase inhibitor; structure in first sourcequinolines
oxalylglycineN-oxalylglycine : An amino dicarboxylic acid that is iminodiacetic acid with an oxo substituent. It is used as an inhibitor of alpha-ketoglutarate dependent (EC 1.14.11.*) enzymes.

oxalylglycine: structure given in first source
amino dicarboxylic acid;
N-acylglycine
EC 1.14.11.* (oxidoreductase acting on paired donors, 2-oxoglutarate as one donor, incorporating 1 atom each of oxygen into both donors) inhibitor